Spok (NASDAQ:SPOK) Releases Quarterly Earnings Results

Spok (NASDAQ:SPOK) announced its quarterly earnings results on Wednesday. The Wireless communications provider reported $0.21 EPS for the quarter, Zacks reports. The business had revenue of $34.91 million for the quarter. Spok had a return on equity of 9.43% and a net margin of 11.27%. Spok updated its FY 2024 guidance to EPS.

Spok Trading Down 8.9 %

Shares of NASDAQ:SPOK traded down $1.40 during trading on Thursday, hitting $14.32. 356,456 shares of the stock were exchanged, compared to its average volume of 147,570. The company has a fifty day moving average price of $16.29 and a two-hundred day moving average price of $15.93. The company has a market cap of $289.98 million, a PE ratio of 18.66 and a beta of 0.27. Spok has a 12-month low of $10.46 and a 12-month high of $18.14.

Spok Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 29th. Stockholders of record on Friday, March 15th were paid a dividend of $0.313 per share. This is a positive change from Spok’s previous quarterly dividend of $0.31. The ex-dividend date of this dividend was Thursday, March 14th. This represents a $1.25 annualized dividend and a dividend yield of 8.74%. Spok’s payout ratio is 162.34%.

Insider Transactions at Spok

In other news, Director Todd J. Stein sold 25,927 shares of the business’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $17.92, for a total transaction of $464,611.84. Following the sale, the director now owns 696,637 shares of the company’s stock, valued at approximately $12,483,735.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 11.88% of the company’s stock.

About Spok

Spok Holdings, Inc, through its subsidiary, Spok, Inc, provides healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. The company's products and services enhance workflows for clinicians and support administrative compliance. It delivers clinical information to care teams when and where it matters to enhance patient outcomes; and provides GenA Pager, a one-way alphanumeric pager.